K286-3610 Screening compound: N-butyl-N-ethyl-2-{[6-(2-fluorophenyl)-3-(2-methylphenyl)-7-oxo-2-sulfanylidene-2H,3H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-5-yl]sulfanyl}acetamide

K286-3610 Screening compound: N-butyl-N-ethyl-2-{[6-(2-fluorophenyl)-3-(2-methylphenyl)-7-oxo-2-sulfanylidene-2H,3H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-5-yl]sulfanyl}acetamide
K286-3610 Screening compound: N-butyl-N-ethyl-2-{[6-(2-fluorophenyl)-3-(2-methylphenyl)-7-oxo-2-sulfanylidene-2H,3H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-5-yl]sulfanyl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K286-3610
N-butyl-N-ethyl-2-{[6-(2-fluorophenyl)-3-(2-methylphenyl)-7-oxo-2-sulfanylidene-2H,3H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-5-yl]sulfanyl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K286-3610

Molecular Formula

C26H27FN4O2S3 (C26 H27 FN4 O2 S3)

Compound Name

N-butyl-N-ethyl-2-{[6-(2-fluorophenyl)-3-(2-methylphenyl)-7-oxo-2-sulfanylidene-2H,3H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-5-yl]sulfanyl}acetamide

IUPAC name

N-butyl-N-ethyl-2-{[6-(2-fluorophenyl)-3-(2-methylphenyl)-7-oxo-2-sulfanylidene-2H3H6H7H-[13]thiazolo[45-d]pyrimidin-5-yl]sulfanyl}acetamide

SMILES

CCCCN(CC)C(CSC(N(c(cccc1)c1F)C1=O)=NC(N2c3c(C)cccc3)=C1SC2=S)=O

InChI

InChI=1S/C26H27FN4O2S3/c1-4-6-15-29(5-2)21(32)16-35-25-28-23-22(24(33)31(25)20-14-10-8-12-18(20)27)36-26(34)30(23)19-13-9-7-11-17(19)3/h7-14H,4-6,15-16H2,1-3H3

InChI Key

QWEPBCTYZUYDDX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15090606

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

542.72

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.528

Distribution Coefficient, logD

5.528

Water Solubility, LogSw

-5.32

Polar Surface Area

42.283

Acid Dissociation Constant (pKa)

28.32

Base Dissociation Constant (pKb)

0.98

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.80

K286-3610 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K286-3610 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K286-3610?
Check Price and Availability of K286-3610, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K286-3610 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K286-3610
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K286-3610
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K286-3610 available by request